Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Celltrion (068270) – New Facility Investment / 2026-03-24

Posted on March 24, 2026August 6, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) – New Facility Investment / 2026-03-24

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion has decided to invest KRW 1.23T (6.98% of equity) in new facility construction to build Plants 4 and 5 (total 180,000L capacity) at its Songdo Campus.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: New Facility Investment
  • Investment Category & Target: New Facility Investment / Construction of Plants 4 and 5 at Songdo Campus (Total 180,000L capacity)
  • Investment Amount: KRW 1,226,500,000,000 (approx. KRW 1.23T)
  • Equity: KRW 17,580,062,368,691 (Based on FY2024 consolidated financial statements)
  • Investment-to-Equity Ratio: 6.98% (Large corporation threshold applies)
  • Investment Objectives:
    • Responding to commercial pipeline expansion and growing market demand, establishing a stable supply chain
    • Preemptively securing production capacity following the full-scale launch of the CDMO business
  • Investment Period: April 1, 2026 ~ December 31, 2030 (End date based on validation completion)
  • Board Resolution Date: March 24, 2026 (All 8 outside directors attended)
  • Key Notes: Investment amount and schedule are subject to change depending on facility licensing, construction progress, and business environment shifts.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Songdo Plants 4 and 5 Investment Progress and Periodic Reports

This disclosure details Celltrion’s decision to invest KRW 1.23T in constructing Songdo Plants 4 and 5 with a total capacity of 180,000L, making it important to monitor capital expenditure and construction progress following the April 1, 2026 start date. Tracking actual execution against the published timeline ensures that capacity expansion aligns with the operational goals for CDMO and commercial product supply. Progress on facility construction and capital expenditure can be verified under ‘Status of Facility Investment’ in upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports).

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Future Business and Management Plan (Correction) / 2026-03-24
Next Post: [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-03-24

Related Posts

[Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-11-17 Semiconductors
[Disclosure] Samsung Electro-Mechanics (009150) – Submission of Audit Report / 2025-02-21 Semiconductors
[Disclosure] ALTEOGEN (196170) – Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2026-02-27 Disclosures
[Disclosure] ISU PETASYS (007660) – Clarification on Rumors or News Reports (Unconfirmed) / 2025-01-02 Semiconductors
[Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2025-10-27 Semiconductors
[Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2024-01-23 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme